PharVision Advisers’s Philip Morris PM Stock Holding History

PharVision Advisers’s Portfolio PM Stock Details PM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,511	Closed	-$302K	–	465
2024 Q4	$302K	Buy	+2,511	New	+$317K	0.26%	148

Other funds holding PM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PharVision Advisers's PM Position: Q1 2025 in Review

PharVision Advisers sold out of Philip Morris (PM) in Q1 2025, closing a stake of 2,511 shares — an estimated $302K sold.

PharVision Advisers first reported a position in PM in Q4 2024 and held it in 1 quarter. The position peaked at $302K in Q4 2024. 2,708 funds tracked by Wall St. Rank hold PM as of Q1 2025.

PharVision Advisers reported no remaining Philip Morris position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 2,511 Philip Morris shares in Q1 2025, an estimated $302K.
PharVision Advisers first reported a position in Philip Morris in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Philip Morris position peaked at $302K in Q4 2024.
2,708 funds tracked by Wall St. Rank held Philip Morris as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.